FenoglioJJJr. The effects of drugs on the cardiovascular system. In: SilverMD, ed. Cardiovasc Pathol1983; 2:1085–107.
2.
AdamsonRH. Daunomycin (NSC — 8215) and Adriamycin (NSC — 123127) hypothesis concerning antitumor activity and cardiotoxicity. Cancer Chemother Rep1974; 58:293–4.
3.
KharaschEDNovakRF. Inhibitions of Adriamycin simulated microsomal lipid peroxidation of mitoxantrone and ametantrone, two new anthracenedione, antineoplastic agents. Biochem Biophys Res Commun1982; 108:1346–52.
4.
MinmaughEGTrushMAGinsburgEGramTE. Differential effects of anthracycline drugs on rat heart and liver microsomal reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation. Cancer Res1982; 42:3574–82.
5.
DoroshowJH. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res1983; 43:4543–51.
6.
DoroshowJHDaviesKJA. Comparative cardiac oxygen radical metabolism by anthracycline antibiotics, mitoxantrone, bisantrene, 4 ′-(-9-acridinylamino)-methanesulfon-M-anisidide and neocarzinostatin. Biochem Pharmacol1983; 32:2935–9.
7.
SparanoBMGordonGHallCIatropoulosMJNobleJF. Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: Comparison with doxorubicin II. Histologic and ultrastructural pathology. Cancer Treat Rep1982; 66:1145–58.
8.
IatropoulosMJ. Anthracycline cardiomyopathy: Predictive value of animal models. Cancer Treat Symp1984; 3:380–7.
9.
Von HoffDDLayardMWBasaP, Risk factors for drug induced congestive heart failure. Ann Intern Med1979; 91:710–7.
10.
DukartG. Cardiac episodes in patients receiving mitoxantrone. In: SmythJF, ed. Pharmanual, a comprehensive guide to the therapeutic use of Novantrone. Chicago: Pharma Libri, 1984 (in press).
11.
HendersonICDukartG. A randomized trial comparing mitoxantrone (M) with doxorubicin (D) in patients (pts) with metastatic breast cancer (BC). Poster (C-470) presented at the American Society of Clinical Oncology meeting in Toronto, May 1984.
12.
AlexanderJDaniakNBergerHJ, Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiography. N Engl J Med1979; 300:278–83.
13.
BenjaminRSChawlaSPEwerMS, Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy. Presented (C-156) at the American Society of Clinical Oncology meeting in Toronto, May 1984.